- Home
- DUO vs COCP Comparison
DUO vs COCP Comparison
Compare DUO & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- COCP
- Stock Information
- Founded
- DUO 2011
- COCP 2006
- Country
- DUO China
- COCP United States
- Employees
- DUO N/A
- COCP N/A
- Industry
- DUO Real Estate
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- DUO Finance
- COCP Health Care
- Exchange
- DUO Nasdaq
- COCP Nasdaq
- Market Cap
- DUO 17.1M
- COCP 15.3M
- IPO Year
- DUO 2019
- COCP N/A
- Fundamental
- Price
- DUO $0.23
- COCP $1.51
- Analyst Decision
- DUO
- COCP Strong Buy
- Analyst Count
- DUO 0
- COCP 1
- Target Price
- DUO N/A
- COCP $7.00
- AVG Volume (30 Days)
- DUO 3.3M
- COCP 13.8K
- Earning Date
- DUO 05-16-2025
- COCP 05-20-2025
- Dividend Yield
- DUO N/A
- COCP N/A
- EPS Growth
- DUO N/A
- COCP N/A
- EPS
- DUO 0.47
- COCP N/A
- Revenue
- DUO $46,458,330.00
- COCP N/A
- Revenue This Year
- DUO N/A
- COCP N/A
- Revenue Next Year
- DUO N/A
- COCP N/A
- P/E Ratio
- DUO $0.48
- COCP N/A
- Revenue Growth
- DUO 19.00
- COCP N/A
- 52 Week Low
- DUO $0.20
- COCP $1.12
- 52 Week High
- DUO $4.67
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- DUO 36.05
- COCP 59.09
- Support Level
- DUO $0.22
- COCP $1.36
- Resistance Level
- DUO $0.25
- COCP $1.74
- Average True Range (ATR)
- DUO 0.02
- COCP 0.17
- MACD
- DUO 0.01
- COCP 0.02
- Stochastic Oscillator
- DUO 20.00
- COCP 71.55
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).